Immuron (IMRN) Operating Expenses (2016 - 2024)
Immuron's (IMRN) quarterly Operating Expenses came in at -$2772.7 billion in Q4 2024, down 60245866.88% year-on-year from N/an in Q1 2024, and down 60245866.88% quarter-over-quarter from -$4.6 million in Q4 2023.
Immuron (IMRN) Operating Expenses (2016 - 2024) Analysis & Trends
Immuron's Operating Expenses history runs 9 years deep, the most recent figure standing at -$2772.7 billion for Q4 2024.
- On a quarterly basis, Operating Expenses fell 60245866.88% year-over-year to -$2772.7 billion in Q4 2024; TTM through Sep 2025 was -$2772.7 billion, a 60245866.88% decrease from a year earlier, with the FY2025 full-year figure at $5.2 million, down 19.59% from the prior year.
- Operating Expenses eased to -$2772.7 billion in Q4 2024 per IMRN's latest filing, from -$4.6 million in the prior quarter.
- Across five years, Operating Expenses topped out at $337933.8 in Q4 2020 and bottomed at -$2772.7 billion in Q4 2024.
- The 5-year median for Operating Expenses is -$501311.3 (2022), against an average of -$462.1 billion.
- Across the five-year window, Operating Expenses fell 26.05% in 2021 and plunged 60245866.88% in 2024, its largest moves.
- Year by year, Operating Expenses stood at $337933.8 in 2020, then fell by 26.05% to $249911.6 in 2021, then slumped by 199.22% to -$247958.7 in 2022, then slumped by 1756.08% to -$4.6 million in 2023, then plunged by 60245866.88% to -$2772.7 billion in 2024.
- Per Business Quant, the three latest IMRN Operating Expenses figures stand at -$2772.7 billion (Q4 2024), -$4.6 million (Q4 2023), and -$754663.8 (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Immuron | 255.19 Mn | 243.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2,772.71 Bn |
| Dec 31, 2023 | -4.60 Mn |
| Jun 30, 2023 | -754,663.83 |
| Dec 31, 2022 | -247,958.71 |
| Dec 31, 2021 | 249,911.60 |
| Dec 31, 2020 | 337,933.81 |
| Dec 31, 2019 | 509,279.32 |
| Dec 31, 2018 | -674,963.00 |
| Dec 31, 2017 | -3.27 Mn |
| Dec 31, 2016 | -2.19 Mn |
| Jun 30, 2016 | -3.69 Mn |